Saba Ilac Sanayi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SABA ILAC SANAYI
SABA ILAC SANAYI has three approved drugs.
Summary for Saba Ilac Sanayi
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Patent Litigation for Saba Ilac Sanayi: | See patent lawsuits for Saba Ilac Sanayi |
Drugs and US Patents for Saba Ilac Sanayi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saba Ilac Sanayive | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 215856-001 | Apr 2, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Saba Ilac Sanayive | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217934-001 | Jul 1, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Saba Ilac Sanayi | ARFORMOTEROL TARTRATE | arformoterol tartrate | SOLUTION;INHALATION | 218429-001 | Apr 25, 2025 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
